Clinical Trial Update: ACT-128800 in Psoriasis [Phase 2]

View source ↗

Summary

Actelion reported the completion of a Phase 2 trial of ACT-128800 in plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ACT-128800

Snippet

Sponsor: Actelion | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED